Olive View–UCLA Medical Center

NYU Langone Health Awarded $13 Million to Create National Center to Promote Diabetes Equity Research

Retrieved on: 
Tuesday, February 6, 2024
Olive, Partnership, NYU Langone Health, Digestive, Family, Kidney failure, Public, Prediabetes, Nerve, Research, Health equity, MD, Caregiver, Patient, UCLA, Kidney, Paratriathlon, Olive View–UCLA Medical Center, School, Organization, American Diabetes Association, Social medicine, MPH, Diabetes, Education, AUC, Trust, Bangladesh Technical Education Board, Community, Type 2 diabetes, Workforce, African Americans, Pharmaceutical industry

To generate more community-engaged diabetes research, the National Institute of Diabetes and Digestive and Kidney Diseases, a division of the National Institutes of Health, has pledged $13 million to NYU Langone Health, Albert Einstein School of Medicine/Montefiore Health System, and UCLA School of Medicine to create the National Center for Engagement in Diabetes Equity Research (CEDER), the first of its kind.

Key Points: 
  • To generate more community-engaged diabetes research, the National Institute of Diabetes and Digestive and Kidney Diseases, a division of the National Institutes of Health, has pledged $13 million to NYU Langone Health, Albert Einstein School of Medicine/Montefiore Health System, and UCLA School of Medicine to create the National Center for Engagement in Diabetes Equity Research (CEDER), the first of its kind.
  • Co-led by Nadia Islam, PhD, associate professor in the Institute for Excellence in Health Equity at NYU Langone, CEDER will create a centralized national infrastructure designed to foster community engagement and participation of diverse populations in Type 2 diabetes research.
  • "It is our hope that everyone committed to advancing equity in diabetes research and care can access the support and mentorship they need."
  • CEDER is funded by the National Institute of Diabetes and Digestive and Kidney Diseases.

Solar Integrated Roofing Corp. Provides Corporate and Operational Update

Retrieved on: 
Thursday, February 1, 2024
Olive, Partnership, DGS, Solar System, Marriott Hotels & Resorts, Community development, EV, Electricity, OTC, SIRC, Water, Department of General Services, Stock split, Liberty, Charger, Olive View–UCLA Medical Center, Insurance, Harbor, Engineering, Energy, SCE

HENDERSON, Nev., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Solar Integrated Roofing Corp. (OTC: SIRC) (“SIRC” or “the Company”), an integrated, single-source solutions provider of solar power, roofing and EV charging systems provides company updates including projects, staffing, share valuation and the Tribeca Energy arrangement.

Key Points: 
  • HENDERSON, Nev., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Solar Integrated Roofing Corp. (OTC: SIRC) (“SIRC” or “the Company”), an integrated, single-source solutions provider of solar power, roofing and EV charging systems provides company updates including projects, staffing, share valuation and the Tribeca Energy arrangement.
  • PLEMCo has been awarded multiple bids over the past several weeks ranging from “installation only” to “design and installation” projects.
  • Housing Community Development - Solar, Canopy and EV Chargers: This project involves design and installation of a parking lot canopy with solar system on top and EV chargers under the canopy.
  • Rich Hadsall is coming back on board focusing on residential solar and roofing sales.

Emerging Markets Report: Building Trust

Retrieved on: 
Tuesday, December 12, 2023
Olive, Editorial, Health care, Person, Yale University, Yale School of Medicine, Ken, Olive View–UCLA Medical Center, Artificial intelligence, Investment, Name, OTCQB, Gerber, Emerging market, Yale school

ORLANDO, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- It’s been a minute since we last covered Medical/A.I. company MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7).

Key Points: 
  • In our last editorial we noted the Company’s transformation to MedBright from Vinergy, a name change that made and makes sense to us given their business model.
  • We strongly encourage you to catch-up in this dynamic, fast-moving Company by reviewing that piece .
  • At the Emerging Markets Report we are cautious and enthusiastic fans of Artificial Intelligence.
  • We believe that it will be one of the most impactful technology drivers in almost every aspect of our lives.

MedBright AI Announces Election of Two US Healthcare Experts to Board of Directors and Approval of New Share Class

Retrieved on: 
Tuesday, December 5, 2023
Olive, DDS, United States Naval Academy, Cardiology, Peripheral artery disease, Patient safety, Class, Freedom, FDA, Medical director, Person, RPVI, Yale University, FACC, Yale School of Medicine, MD, VMD, Moyamoya disease, Olive View–UCLA Medical Center, Investment, Artificial intelligence, Quality, News, Indian stock exchange, OTCQB, Coronary artery disease, Iraq War, HIPPA, Security (finance)

He has broad experience in medical systems management and healthcare start-ups.

Key Points: 
  • He has broad experience in medical systems management and healthcare start-ups.
  • She has over 25 years of experience as a dynamic, visionary leader in healthcare and the military.
  • Michael Dalsin, Chairman of the Investment Committee says, “Both Dr. Gerber and Dr. Wilks have a proven track record as leaders in healthcare services.
  • As a large shareholder, I was pleased to see their appointment to the Board of Directors.

Los Angeles Cancer Network Opens New Location in Santa Clarita

Retrieved on: 
Tuesday, September 19, 2023
Olive, Cedars-Sinai Medical Center, University, Internal medicine, Patient, Central European, Cancer, Olive View–UCLA Medical Center, Physician, Semmelweis University, Keck School of Medicine of USC, Harbor–UCLA Medical Center, University of Mississippi Medical Center, Nursing

SANTA CLARITA, Calif., Sept. 19, 2023 /PRNewswire/ -- Los Angeles Cancer Network (LACN) has been a trusted provider of cancer and blood disorder care in the Los Angeles area for over 30 years.

Key Points: 
  • SANTA CLARITA, Calif., Sept. 19, 2023 /PRNewswire/ -- Los Angeles Cancer Network (LACN) has been a trusted provider of cancer and blood disorder care in the Los Angeles area for over 30 years.
  • Last week, on September 12, 2023, the ribbon was cut at their newest location at 25425 Orchard Village Rd.
  • Suite 150, Santa Clarita, CA 91355, where they will be providing world-class care to patients in the Santa Clarita and surrounding communities.
  • Board-certified hematologist/oncologists Dr. Sheila Vasan and Dr. Krisztina Larson will practice at the newest location in Santa Clarita.

Solar Integrated Roofing Corp. Issues Project and Business Update Letter to Shareholders

Retrieved on: 
Thursday, June 1, 2023
Hydrogen, Olive, EV, Culture, SME, EVSE, Small Commercial Vehicle, Olive View–UCLA Medical Center, Engineering, OTC, Communication, Growth, Commercial, SIRC, Renewable energy, Management, Balance

HENDERSON, Nev., June 01, 2023 (GLOBE NEWSWIRE) -- Solar Integrated Roofing Corp. (OTC:SIRC) (“SIRC” or the Company”), an integrated, single-source solutions provider of solar power, roofing and EV charging systems, today issued a project and business update letter to shareholders from the Company’s Chief Executive Officer, Brad Rinehart, and President/COO, Troy Clymer.

Key Points: 
  • HENDERSON, Nev., June 01, 2023 (GLOBE NEWSWIRE) -- Solar Integrated Roofing Corp. (OTC:SIRC) (“SIRC” or the Company”), an integrated, single-source solutions provider of solar power, roofing and EV charging systems, today issued a project and business update letter to shareholders from the Company’s Chief Executive Officer, Brad Rinehart, and President/COO, Troy Clymer.
  • In addition, we expect our residential solar and roofing business to continue to grow as we expand into new markets.
  • SIRC has completed the design and engineering phase of the project and has negotiated terms for the 8 Mw solar array.
  • We are actively working with our development and project teams, including partners, to advance this project.

Care First, Jails Last. Modular Construction Makes a Way for Mental Health.

Retrieved on: 
Tuesday, April 26, 2022
Olive, Ageing, Health, Woman, COVID-19, Olive View–UCLA Medical Center, Homelessness, Education, Leadership in Energy and Environmental Design, Abbott, Multimedia, Gold, Hospital, County

SYLMAR, Calif., April 26, 2022 /PRNewswire/ -- The new Restorative Care Village at Olive View-UCLA Medical Center has opened as a bold local solution to the cycle of homelessness, hospitalization, and jail associated with mental health challenges.

Key Points: 
  • Built by Abbott Construction, the village features eight buildings over a sprawling, shaded campus.
  • Services include urgent care, post-acute care, wellness therapy, and transitional residential housing.
  • It's a one-stop shop for those in crisis to get immediate help and embark on a path of long-term healing.
  • Founded in 1983, Abbott Construction is a West Coast construction group known for superior management and field team, best-in-class standards and craftsmanship.

UCLA Study Reveals Wearing GDEFY® Shoes Reduces Knee Pain by up to 85%

Retrieved on: 
Wednesday, April 13, 2022
Olive, Olive View–UCLA Medical Center, Knee pain, Pain, Human, Journal of the American Podiatric Medical Association, Pain management, Back pain, Workplace, ACHES, LOS, Shoe, Walking, Knee, Therapy, Heel, Journal, Ankle, Southern Discomfort (Eyehategod album), Multimedia, Ronald Reagan UCLA Medical Center, American Podiatric Medical Association, UCLA, Poultry, Shoemaking

LOS ANGELES, April 12, 2022 /PRNewswire/ -- With one in four American adults suffering from chronic knee pain[1], a promising study out of UCLA points to a viable, non-surgical solution: GDEFY® medically engineered shoes. In fact, study participants wearing the GDEFY shoes with patented VersoShock® technology reported an average reduction in knee pain of 85%, as well as significant decreases in other common conditions including back, ankle, and foot pain.

Key Points: 
  • In fact, study participants wearing the GDEFY shoes with patented VersoShocktechnology reported an average reduction in knee pain of 85%, as well as significant decreases in other common conditions including back, ankle, and foot pain.
  • A double-blind, randomized study conducted at Olive View UCLA Medical Center, recently published in the Journal of the American Podiatric Medical Association ,shows wearing shoes with VersoShock soles decreases knee pain by up to 85% vs. wearing shoes with conventional soles during prolonged standing and walking.
  • In the UCLA study, fifty-two adults with overuse symptoms of knee pain were enrolled and randomly assigned to use the intervention sole or the traditional sole shoes.
  • It worked better than he ever imagined, not just for heel pain but also for back pain, knee pain, and a host of other aches and discomforts.

National Advertising Division Refers Advertising Claims for Gravity Defyer Shoes to Federal Trade Commission for Possible Enforcement Action

Retrieved on: 
Tuesday, September 14, 2021
Olive, Walking, Back pain, Privacy, Council, Federal Trade Commission, Plantar fasciitis, Ronald Reagan UCLA Medical Center, Advertising, Arthralgia, Human back, Association of National Advertisers, FTC, Industry, NAD, Olive View–UCLA Medical Center, Review, Multimedia, Better Business Bureau, Compliance, Knee, Fasciitis, Shoe, Gravity, CARU, Dietary supplement

NEWYORK, Sept. 14, 2021 /PRNewswire/ --The National Advertising Division (NAD) of BBB National Programs is disappointed that Gravity Defyer Medical Technology Corporation declined to participate in the industry self-regulation process.

Key Points: 
  • NEWYORK, Sept. 14, 2021 /PRNewswire/ --The National Advertising Division (NAD) of BBB National Programs is disappointed that Gravity Defyer Medical Technology Corporation declined to participate in the industry self-regulation process.
  • As a result of the advertiser's failure to participate, NAD has referred advertising claims for their Gravity Defyer shoes to the Federal Trade Commission (FTC) for review.
  • In 2019, NAD requested that Gravity Defyer Medical Technology Corporation provide evidence that it complied with a 2011 NAD decision to discontinue certain health-related claims for Gravity Defyer shoes.
  • About the National Advertising Division:TheNational Advertising Division (NAD) of BBB National Programsprovidesindependent self-regulationand dispute resolution services,guidingthe truthfulness of advertising across the U.S. NADreviews national advertising in all media and its decisions set consistent standards foradvertisingtruth and accuracy, delivering meaningful protection toconsumersand leveling the playing field for business.

Atlas Awarded $3 Million Inspection and Materials Testing Contract with Los Angeles County Public Works

Retrieved on: 
Tuesday, May 18, 2021
UCLA Health, Hospitals in California, Neighborhoods in Los Angeles, Healthcare in California, Trauma centers, Ronald Reagan UCLA Medical Center, Inspection, Olive View–UCLA Medical Center, Harbor–UCLA Medical Center, LAC+USC Medical Center

b'AUSTIN, Texas, May 18, 2021 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (\xe2\x80\x9cAtlas\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), a leading Infrastructure and Environmental services provider, announced today that it was awarded a $3 million contract to provide on-call special inspection and materials testing in various healthcare facilities for the Los Angeles County Department of Public Works.

Key Points: 
  • b'AUSTIN, Texas, May 18, 2021 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (\xe2\x80\x9cAtlas\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), a leading Infrastructure and Environmental services provider, announced today that it was awarded a $3 million contract to provide on-call special inspection and materials testing in various healthcare facilities for the Los Angeles County Department of Public Works.
  • Facilities include Harbor-UCLA Medical Center, Los Angeles County-USC Medical Center, Martin Luther King Jr. Medical Center and Olive View-UCLA Medical Center.\nHeadquartered in Austin, Texas, Atlas is a leading provider of Environmental (ENV), Testing, Inspection & Certification (TIC), Engineering & Design (E&D), and Program, Construction, and Quality Management (PCQM) services.
  • Under the name Atlas Technical Consultants, we offer solutions to public and private sector clients in the transportation, commercial, water, government, education, and industrial markets.
  • With approximately 3,500 employees and a nationwide footprint, Atlas provides a broad range of mission-critical technical services, helping clients test, inspect, certify, plan, design, and manage a wide variety of projects across diverse end markets.